Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-O-(4,6-dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-beta-D-lyxo-hexopyranosyl)-alpha-D-erythro-hexopyranose
- Development stage
- Unknown
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Acarbose derived trisaccharide is a synthetic or natural compound related to the structure of acarbose and its metabolites. It belongs to the class of aminocyclitol glycosides and has been reported in Streptomyces diastaticus. The compound is considered experimental and has not been approved for any clinical use. Its mechanism of action is presumed similar to that of acarbose—an inhibitor of alpha-glucosidase enzymes—which delays carbohydrate digestion in the intestine and reduces postprandial blood glucose levels. However, this specific derivative does not have documented clinical indications or approvals[2][7].
- Other names
- acarbose derived trisaccharide4-O-(4,6-dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-y1]amino}-beta-D-Lyxo-Hexopyranosyl)-alpha-D-Erythro-Hexopyranose
02
Targets
Sucrase-Isomaltase
Beyond the preview
Go deeper on 4-O-(4,6-dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-beta-D-lyxo-hexopyranosyl)-alpha-D-erythro-hexopyranose.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 4-O-(4,6-dideoxy-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}-beta-D-lyxo-hexopyranosyl)-alpha-D-erythro-hexopyranose.